As a target gene of miR-10a, the PI3K p100 catalytic subunit α (PIK3CA) plays a critical role in the cisplatin resistance of lung adenocarcinoma circulating tumor cells via the in PI3K/Akt pathway [9]. The gene discussed is AKT1; the disease is neoplasm.